“If something happens, a patient dies, we will not be able to question them (Pfizer). If somebody challenges in a court of law, the central government will be responsible for everything, not the company,” the source added.
Pfizer declined to comment, citing ongoing discussions with the government. India’s health ministry did not reply to Reuters requests for comment on Friday.
AC
Views: